BPC-157 and TB-500 "The Wolverine Stack"

BPC-157 and TB-500 "The Wolverine Stack"

In Episode 3 of Peptides Explained, we take a closer look at two of the most talked-about peptides in injury recovery circles: BPC-157 and TB-500.

These compounds are often combined in what’s popularly called the “Wolverine Stack,” a nickname that reflects claims of accelerated healing and recovery. But what are these peptides actually doing in the body, and what does the science really say?

In this episode, we break down the biology behind both compounds, how they interact with tissue repair pathways, and why they’ve become so popular in athletic and performance communities.

We discuss:

• What BPC-157 is and how it may influence angiogenesis, tendon repair, and tissue healing
• What TB-500 (a fragment related to thymosin beta-4) does in terms of cell migration and tissue remodeling
• The biological rationale behind combining the two peptides
• What the available animal research suggests — and where human clinical data is still lacking
• Why these peptides remain in a regulatory gray area
• The difference between experimental compounds and FDA-approved peptide therapeutics

The goal of Peptides Explained is clarity, not hype. In each episode we examine the mechanisms, the available data, and the real limitations of what we know today.

Disclaimer:
This podcast is for informational purposes only and does not constitute medical advice. Peptides discussed may have different regulatory statuses and should only be used under the guidance of licensed healthcare professionals.

If you’re interested in the science behind peptides, injury recovery, metabolism, and emerging therapeutic pathways, this episode will give you a clear, evidence-based overview of one of the most talked-about peptide combinations today.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(17)

Do Growth Hormone Peptides Cause Cancer? | The Truth About IGF-1

Do Growth Hormone Peptides Cause Cancer? | The Truth About IGF-1

Do growth hormone secretagogues increase cancer risk?This episode breaks down the real science behind IGF-1, cancer biology, and compounds like MK-677, Ipamorelin, Sermorelin, CJC-1295, and Tesamoreli...

25 Mai 15min

BPC-157 and Cancer: What the Studies Actually Show

BPC-157 and Cancer: What the Studies Actually Show

Does BPC-157 cause cancer — or is that claim being oversimplified?In this episode of Peptides Explained, we take a study-review approach to one of the biggest concerns surrounding BPC-157: its potenti...

18 Mai 30min

Tesamorelin Explained: Visceral Fat, Growth Hormone & Real-World Outcomes

Tesamorelin Explained: Visceral Fat, Growth Hormone & Real-World Outcomes

Tesamorelin is one of the few peptides with FDA approval—but its effects on visceral fat and growth hormone signaling have made it a major topic in metabolic health and body composition circles.In thi...

11 Mai 8min

Special Announcement: New Partnership for Peptides Explained

Special Announcement: New Partnership for Peptides Explained

In this special update episode, I’m announcing a new affiliate partnership between Peptides Explained and Offline Peptides.The mission of this podcast remains unchanged:providing clear, responsible, s...

7 Mai 36s

Retatrutide Explained: The Triple Agonist Changing Obesity Medicine

Retatrutide Explained: The Triple Agonist Changing Obesity Medicine

Retatrutide may represent the next evolution in metabolic medicine.In this deep-dive episode of Peptides Explained, we break down the science behind the investigational “triple agonist” peptide that’s...

6 Mai 12min

Minimal Effective Dose: The Key to Preventing Muscle Loss on GLP-1s

Minimal Effective Dose: The Key to Preventing Muscle Loss on GLP-1s

Using the minimal effective dose of GLP-1 medications may be the key to preserving muscle during weight loss. This episode explains how to implement it alongside nutrition and training.

28 Apr 15min

GLP-1 Drugs... Are They Destroying Muscle? — What Semaglutide, Tirzepatide & Retatrutide Data Actually Shows

GLP-1 Drugs... Are They Destroying Muscle? — What Semaglutide, Tirzepatide & Retatrutide Data Actually Shows

A clinical deep dive into the muscle loss problem on GLP-1 medications. Semaglutide, tirzepatide, and the investigational triple agonist retatrutide all produce remarkable weight loss — but clinical t...

22 Apr 21min

The Peptide Ban Is Ending: FDA Officially Begins Reclassification Process for BPC-157, TB-500 & More

The Peptide Ban Is Ending: FDA Officially Begins Reclassification Process for BPC-157, TB-500 & More

Breaking news episode. On April 15, 2026, the FDA formally initiated the reclassification process for BPC-157, TB-500, and other peptides restricted since 2023 — publishing a Federal Register notice a...

16 Apr 24min

Populært innen Helse

fastlegen
rss-gukild-johaug
psykodrama
hvordan-har-du-det-mann
lydartikler-fra-aftenposten
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
rss-garne-damer
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-skravla-gar
morten-ramm-lar-kakla-ga-til-du-sovner
klimaks
rss-lopedrommen
hjernesterk
g-punktet
sinnsyn
rss-kunsten-a-leve
hverdagspsyken
helsetipspodden